Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications.

The ability to culture hematopoietic cells in readily characterizable and scalable stirred systems, combined with the capability to utilize serum-free medium, will aid the development of clinically attractive bioreactor systems for transplantation therapies. We thus examined the proliferation and differentiation characteristics of peripheral blood (PB) mononuclear cells (MNC), cord blood (CB) MNC, and PB CD34(+) cells in spinner flasks and (control) T-flask cultures in both serum-containing and serum-free media. Hematopoietic cultures initiated from all sources examined (PB MNC, CB MNC, and PB CD34(+) cells) grew well in spinner vessels with either serum-containing or serum-free medium. Culture proliferation in spinner flasks was dependent on both agitator design and RPM as well as on the establishment of critical inoculum densities (ID) in both serum-containing (2 x 10(5) MNC/mL) and serum-free (3 x 10(5) MNC/mL) media. Spinner flask culture of PB MNC in serum-containing medium provided superior expansion of total cells and colony-forming cells (CFC) at high ID (1.2 x 10(6) cells/mL) as compared to T-flask controls. Serum-free spinner culture was comparable, if not superior, to that observed in serum-containing medium. This is the first report of stirred culture of PB or CB MNC, as well as the first report of stirred CD34(+) cell culture. Additionally, this is the first account of serum-free stirred culture of hematopoietic cells from any source.

[1]  J G Bender,et al.  Effects of CD34+ cell selection and perfusion on ex vivo expansion of peripheral blood mononuclear cells. , 1995, Blood.

[2]  J G Bender,et al.  Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. , 1996, Blood.

[3]  C. Verfaillie,et al.  Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. , 1993, Blood.

[4]  P. Insel,et al.  Clonal growth of lymphoid cells in serum‐free media requires elimination of H2O2 toxicity , 1983, Journal of cellular physiology.

[5]  J. Dasch,et al.  Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta. , 1994, Experimental hematology.

[6]  M. Roncarolo,et al.  Immune functions of cord blood cells before and after transplantation. , 1996, Journal of hematotherapy.

[7]  S. Emerson,et al.  Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. , 1993, Blood.

[8]  Peter W. Zandstra,et al.  Expansion of Hematopoietic Progenitor Cell Populations in Stirred Suspension Bioreactors of Normal Human Bone Marrow Cells , 1994, Bio/Technology.

[9]  A. Kessinger Do autologous peripheral blood cell transplants provide more than hematopoietic recovery? , 1995, Stem cells.

[10]  J. Miller,et al.  Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor. , 1996, Journal of hematotherapy.

[11]  A. Sinskey,et al.  Mathematical descriptions of hybridoma culture kinetics: II. The relationship between thiol chemistry and the degradation of serum activity , 1989, Biotechnology and bioengineering.

[12]  E. Papoutsakis,et al.  Comparison of whole serum-deprived media for ex vivo expansion of hematopoietic progenitor cells from cord blood and mobilized peripheral blood mononuclear cells. , 1996, Journal of hematotherapy.

[13]  David A. Williams,et al.  The use of umbilical cord blood as a cellular source for correction of genetic diseases affecting the hematopoietic system , 1995, Stem cells.

[14]  E. Papoutsakis,et al.  Increased agitation intensity increases CD13 receptor surface content and mRNA levels, and alters the metabolism of HL60 cells cultured in stirred tank bioreactors. , 1998, Biotechnology and bioengineering.

[15]  E. Papoutsakis,et al.  Sparging and agitation‐induced injury of cultured animals cells: Do cell‐to‐bubble interactions in the bulk liquid injure cells? , 2000, Biotechnology and bioengineering.

[16]  I. Dybedal,et al.  Transforming growth factor beta (TGF-beta), a potent inhibitor of erythropoiesis: neutralizing TGF-beta antibodies show erythropoietin as a potent stimulator of murine burst-forming unit erythroid colony formation in the absence of a burst-promoting activity. , 1995, Blood.

[17]  W M Miller,et al.  Real-time method for determining the colony-forming cell content of human hematopoietic cell cultures. , 1997, Biotechnology and bioengineering.

[18]  E. Papoutsakis,et al.  Serum‐free media for cultures of primitive and mature hematopoietic cells , 1994, Biotechnology and bioengineering.

[19]  C A Sardonini,et al.  Expansion and Differentiation of Human Hematopoietic Cells from Static Cultures through Small‐Scale Bioreactors , 1993, Biotechnology progress.

[20]  Eleftherios T. Papoutsakis,et al.  Expansion of Primitive Human Hematopoietic Progenitors in a Perfusion Bioreactor System with IL-3, IL-6, and Stem Cell Factor , 1993, Bio/Technology.

[21]  M. Warren,et al.  CD34+ cell expansion and expression of lineage markers during liquid culture of human progenitor cells , 1995, Stem cells.

[22]  W M Miller,et al.  Culture materials affect ex vivo expansion of hematopoietic progenitor cells. , 1997, Journal of biomedical materials research.

[23]  P. Quesenberry,et al.  Stromal Regulation of Hematopoiesis , 1989, Annals of the New York Academy of Sciences.

[24]  S. Heimfeld,et al.  Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. , 1995, Journal of hematotherapy.

[25]  P. Pedrazzoli,et al.  Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. , 1997, Blood.

[26]  J G Bender,et al.  Development of novel perfusion chamber to retain nonadherent cells and its use for comparison of human “mobilized” peripheral blood mononuclear cell cultures with and without irradiated bone marrow stroma , 2000, Biotechnology and bioengineering.